Page last updated: 2024-09-04

moxifloxacin and Obesity, Morbid

moxifloxacin has been researched along with Obesity, Morbid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Horbach, T; Kees, F; Kees, MG; Weber, S	1

Trials

1 trial(s) available for moxifloxacin and Obesity, Morbid

Article	Year
Pharmacokinetics of moxifloxacin in plasma and tissue of morbidly obese patients. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:10 Topics: Adipose Tissue; Adult; Anti-Infective Agents; Aza Compounds; Biological Availability; Body Composition; Body Mass Index; Female; Fluoroquinolones; Gastric Bypass; Humans; Intestine, Small; Male; Middle Aged; Moxifloxacin; Obesity, Morbid; Omentum; Quinolines; Tissue Distribution	2011

Article

Year

Pharmacokinetics of moxifloxacin in plasma and tissue of morbidly obese patients.

The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:10

Topics: Adipose Tissue; Adult; Anti-Infective Agents; Aza Compounds; Biological Availability; Body Composition; Body Mass Index; Female; Fluoroquinolones; Gastric Bypass; Humans; Intestine, Small; Male; Middle Aged; Moxifloxacin; Obesity, Morbid; Omentum; Quinolines; Tissue Distribution

2011